MENU
+Compare
ALDX
Stock ticker: NASDAQ
AS OF
Sep 3 closing price
Price
$5.83
Change
+$0.08 (+1.39%)
Capitalization
350.73M

ALDX Aldeyra Therapeutics Forecast, Technical & Fundamental Analysis

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases... Show more

Industry: #Biotechnology
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALDX with price predictions
Sep 02, 2025

ALDX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for ALDX moved above the 200-day moving average on August 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 12, 2025. You may want to consider a long position or call options on ALDX as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALDX advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 206 cases where ALDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ALDX moved out of overbought territory on August 29, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where ALDX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ALDX turned negative on August 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALDX broke above its upper Bollinger Band on August 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.345) is normal, around the industry mean (19.852). P/E Ratio (0.000) is within average values for comparable stocks, (51.814). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.136). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (322.082).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALDX is expected to report earnings to rise 53.13% to -24 cents per share on November 13

Aldeyra Therapeutics ALDX Stock Earnings Reports
Q3'25
Est.
$-0.25
Q2'25
Beat
by $0.08
Q1'25
Beat
by $0.12
Q4'24
Missed
by $0.03
Q3'24
Missed
by $0.01
The last earnings report on August 08 showed earnings per share of -15 cents, beating the estimate of -24 cents. With 514.34K shares outstanding, the current market capitalization sits at 350.73M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for eye diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
131 Hartwell Avenue
Phone
+1 781 761-4904
Employees
10
Web
https://www.aldeyra.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFRUY17.530.21
+1.21%
Compagnie Financiere Richemont AG
MTLHY27.96N/A
N/A
Mitsubishi Chemical Group Corporation
UBEOF15.28N/A
N/A
UBE CORPORATION
ACXAF3.45N/A
N/A
ACT Energy Technologies Ltd.
DTARF0.10N/A
-0.94%
Delta Resources Limited

ALDX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
+1.39%
GSGTF - ALDX
56%
Loosely correlated
N/A
PLRX - ALDX
38%
Loosely correlated
+2.09%
ARVN - ALDX
37%
Loosely correlated
N/A
CGON - ALDX
36%
Loosely correlated
+4.41%
MGTX - ALDX
32%
Poorly correlated
+0.41%
More